Last updated on February 2018

AML Treatment in Untreated Adult Patients


Brief description of study

The present therapy intends to be an homogeneous treatment for AML patients based on a pretreatment with hydroxiurea plus an induction therapy with the standard arm with Daunorubicine as according to EORTC-GIMEMA AML10 study.

The post-remissional treatment is based on transplant with HLA compatible donor is foreseen for all patients and autologous transplant for those without HLA compatible donor available.

Detailed Study Description

GIMEMA treatment for adult (15-60 yrs) AML patients included a 3-drug induction cycle with DNR (50 mg/m2 d 1, 3, 5), cytarabine (100 mg/m2 d1-10), etoposide (100 mg/m2 d1-5) followed by an intensive consolidation with cytarabine (500 mg/m2/q12 hrs d1-d6) and the same anthracycline as in induction on d 4-6. Following consolidation, eligible pts (age <45 or 55 yrs) with a HLA compatible sibling had to be allografted, the others, had to be autografted with autologous peripheral stem cell (PSC) collected during recovery from consolidation.

BM and PB samples at diagnosis were centralized according to a national GIMEMA original study planned with the aim to accurately evaluate biological characteristics at diagnosis and to identify genetic alterations with prognostic relevance and to follow up cases monitoring minimal disease during remission. To allow the adequate collection and sending of samples before starting intensive chemotherapy, all patients received a 5-day pretreatment consisting of hydroxiurea (HU) at the dosage of 2 g/m2/day, also effective for "debulkying" of disease.

Clinical Study Identifier: NCT00449319

Contact Investigators or Research Sites near you

Start Over

Prof. Mozzana

Gallarate, Italy
  Connect »

Prof. D'Arco

Nocera Inferiore, Italy
  Connect »

Dr Avanzi

Novara, Italy
  Connect »

Prof. Saglio

Orbassano, Italy
  Connect »

Dr Mirto

Palermo, Italy
  Connect »

Dr. Nobile

Reggio Calabria, Italy
  Connect »

Pr. Carella

San Giovanni Rotondo, Italy
  Connect »

Dr Epis

Sondalo, Italy
  Connect »

Dr. Russo

Taormina, Italy
  Connect »

Dr Mazza

Taranto, Italy
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.